The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma. - Isa, Reiko; Horinaka, Mano; Tsukamoto, Taku; Mizuhara, Kentaro; Fujibayashi, Yuto; Taminishi-Katsuragawa, Yoko; Okamoto, Haruya; Yasuda, Shusuke; Kawaji-Kanayama, Yuka; Matsumura-Kimoto, Yayoi; Mizutani, Shinsuke; Shimura, Yuji; et al. (International Journal of Molecular Sciences, 2022)